$VICR

Vicor Shares Jump Nearly 9.9% After Company Raises Third-Quarter Revenue Outlook

Vicor Corporation (VICR) raised its Q3 2026 revenue outlook to over 20% sequential growth, up from nearly 10%, due to royalty income from its VPD licensing program. Four companies, including major OEMs, have licensed the technology. The company also expanded manufacturing and authorized a $150M share buyback. Shares rose nearly 9.9% in premarket trading.

Original reporting
Published Sep 22, 2026, 10:49 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 11:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Vicor Shares Jump Nearly 9.9% After Company Raises Third-Quarter Revenue Outlook — source image
Decision brief

The 30-second read

$VICRBullishMed
01

Why it matters

The guidance lift and buyback are likely to support short‑term price appreciation, especially given the pre‑market move.

02

Market read

New guidance and capital return signal improved financial outlook, making Vicor a near‑term trade candidate.

03

What to watch

Regulatory import restrictions could accelerate licensing but also expose Vicor to litigation risk.

Relevance 8/10Novelty 8/10Timing: premarket today

Background

Vicor previously reported Q2 results 63 days ago; this article provides the first update on Q3 outlook and a new share buyback program.

Company-level read

Ticker impact

$VICRBullishHigh confidence
Context

Vicor raised Q3 2026 revenue outlook to >20% sequential growth and announced a $150M share repurchase, driving a 9.9% pre‑market price jump.

Expected impact

Potential further upside if guidance holds; watch for follow‑through on licensing deals.

Evidence & confidence

New revenue guidance and sizable buyback are fresh, material information not previously disclosed.

Market effects

Power electronics and licensing revenue models may see increased investor interest.

U.S. tech hardware sector could benefit from perceived growth in VPD licensing.

Potential ripple to OEMs and hyperscale operators evaluating licensing costs.

Counterpoint

Guidance may be optimistic if licensing uptake slows; watch for execution risk.

Key entities

  • Patrizio Vinciarelli

    CEO of Vicor, provided commentary on licensing and growth.

Related articles

$BABAMed

Stocks making the biggest moves premarket: Alibaba, Quest Diagnostics, On Holding, GameStop & more

Alibaba shares rose 3% after its CEO announced plans for 20+ gigawatts of data centers by 2032 and launched a new chip. Quest Diagnostics and Labcorp fell 5% each due to Medicare payment adjustments. Vicor gained 9% on strong Q3 guidance. On Holding jumped 6% after setting new financial targets and a $1B share buyback plan. GameStop rose 3.5% after its CEO bought 1.2M shares.

$DGXMed

Premarket movers: Quest, Labcorp hit by CMS cuts

U.S. stock index futures steadied on Tuesday. Quest Diagnostics (DGX) fell 6.9% and Labcorp (LH) dropped 4.5% after CMS proposed cuts to lab reimbursements. On Holding (ONON) rose 6.4% on a $1B share buyback plan. Vicor (VICR) surged 9.9% after raising Q3 revenue outlook. Endava (DAVA) fell 12% due to CFO investigation. GameStop (GME) gained 3.5% after CEO bought shares. AnaptysBio (ANAB) rose 3.8% on better-than-expected revenue.

$VICRHighAI 8/10

VICR Looks 228.4% Overvalued on GF Value™

Vicor Corp (VICR) shares rose 12% after-hours after revising Q3 revenue growth forecast to over 20%, up from 10%, due to new licensing agreements. GF Value™ rates VICR 228.4% overvalued at $223.90. GF Score™ is 81, with strong growth and profitability but poor valuation. Insiders sold $410.6M in shares over 12 months.